GE Healthcare announces results of Optison heart ultrasound contrast agent presented at ASE
Links shared publicly online about this topic.
- 220total visits
GE Healthcare announces results of Optison heart ultrasound contrast agent presented at ASE
Today, GE Healthcare Medical Diagnostics announced results of a study that evaluated the cardiopulmonary safety of Optison- (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in improving suboptimal echocardiograms.
View full resource at news-medical.net
Tags: Heart, Imaging Tests, Ultrasound, Healthcare, Safety, Medical
Most Recently Shared on June 14, 2011 at 9:14 am By:
Pregnancy News: GE Healthcare announces results of Optison heart ultrasound contrast agent presented at ASE: Tod... http://bit.ly/ixkMHO
Also Shared By:
Advertisement
News-Medical.Net
@NewsMedical
GE Healthcare announces results of Optison heart ultrasound contrast agent presented at ASE: Today, GE Healthcar... http://bit.ly/ixkMHO
1 year ago...